These results demonstrate that HFD- and PA-mediated lipotoxicity downregulate SELENOM expression, and deletion of SELENOM worsens the development of HFD-induced NAFLD hepatic injury. The gene discussed is SELENOM; the disease is metabolic dysfunction-associated steatotic liver disease.